Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11709566 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel;   Procedure: Surgery
2 Recruiting Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Metformin;   Drug: Placebo

Indicates status has not been verified in more than two years